Home › Steatotic Liver Disease › Ohio › Dayton
Steatotic Liver Disease clinical trials in Dayton, OH
8 studies for Steatotic Liver Disease are looking for participants at sites in and around Dayton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Dayton
- 89bio Clinical Study Site, Dayton
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Dayton
- 89bio Clinical Study Site, Dayton
- 89bio Clinical Study Site, Springboro · 14 mi away
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
RecruitingPhase 3
- GSK Investigational Site, Springboro · 14 mi away
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RecruitingPhase 3
- Dayton Gastroenterology - Beavercreek, Beavercreek · 8 mi away
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RecruitingPhase 3
- Akero Clinical Study Site, Springboro · 14 mi away
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
RecruitingPhase 3
- GSK Investigational Site, Springboro · 14 mi away
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RecruitingPhase 2
- Digestive Specialists, Dayton
- DSI Research, Springboro · 14 mi away
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RecruitingPhase 3
- GSK Investigational Site, Springboro · 14 mi away
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- New York City, NY16 studies
- Miami, FL16 studies
- San Diego, CA14 studies
- Houston, TX13 studies
- Austin, TX13 studies
- Richmond, VA12 studies
- Chandler, AZ10 studies
- Tucson, AZ10 studies
- Hialeah, FL9 studies
- Dallas, TX9 studies
- St. Louis, MO9 studies
Other studies in Dayton
- Lung Cancer14 studies
- Non-Small Cell Lung Cancer13 studies
- Ovarian Cancer9 studies
- Heart Failure8 studies
- Melanoma7 studies
- Cancer (all types)7 studies
- Endometrial Cancer7 studies
- Breast Cancer7 studies
- Prostate Cancer7 studies
- Obesity7 studies
- Overweight6 studies
- Ulcerative Colitis6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.